Abstract:RNAs have diverse structures that are important for biological function. These structures include bulges and internal loops that can form tertiary contacts or serve as ligand binding sites. The most commonly exploited RNA drug target for small molecule intervention is the bacterial ribosome, more specifically the rRNA aminoacyl-tRNA site (rRNA A-site) which is a major target for the aminoglycoside class of antibiotics. The bacterial A-site is composed of a 1 x 1 nucleotide all-U internal loop and a 2 x 1 nucleotide all-A internal loop separated by a single GC base pair. Therefore, we probed the molecular recognition of a small library of four aminoglycosides for binding a 16384-member bacterial rRNA A-site-like internal loop library using two-dimensional combinatorial screening (2DCS). 2DCS is a microarray-based method that probes RNA and chemical spaces simultaneously. These studies sought to determine if aminoglycosides select their therapeutic target if given a choice of binding all possible internal loops derived from an A-site-like library. Results show that the bacterial rRNA A-site was not selected by any aminoglycoside. Analyses of selected sequences using the RNA Privileged Space Predictor (RNA-PSP) program show that each aminoglycoside preferentially binds different types of internal loops. For three of the aminoglycosides, 6''-azido-kanamycin A, 5-O-(2-azidoethyl)-neamine, and 6''-azido-tobramycin, the selected internal loops bind with approximately 10-fold higher affinity than the bacterial rRNA A-site. The internal loops selected to bind 5''-azido-neomycin B bind with an affinity similar to that of the therapeutic target. Selected internal loops that are unique for each aminoglycoside have dissociation constants ranging from 25 to 270 nM and are specific for the aminoglycoside they was selected to bind compared to the other arrayed aminoglycosides. These studies further establish a database of RNA motifs that are recognized by small molecules that could be used to enable the rational and modular design of small molecules targeting RNA.

Synthesis and biological evaluation of neamine analogues for RNA binding

Synthesis and Evaluation of Novel Neamine-Nucleoside Conjugates as Potential Antibiotic Targets for Escherichia coli 16S Ribosomal RNA

Synthesis and Evaluation of Novel Neamine Derivatives Effectively Targeting to RNA

Synthesis and Biological Evaluation of Novel Neamine–nucleoside Conjugates Potentially Targeting to RNAs

Nosiheptide Analogues As Potential Antibacterial Agents Via Dehydroalanine Region Modifications: Semi-synthesis, Antimicrobial Activity and Molecular Docking Study.

Synthesis Of Neamine-Derived Pseudodisaccharides By Stereo- And Regio-Selective Functional Group Transformations

Synthesis of neamine–carboline conjugates for RNA binding and their antibacterial activities

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, Synthesis, and Bioassay of 5-Epi-aminoglycosides.

Synthesis of Aminodisaccharide–nucleoside Conjugates for RNA Binding

Structural analysis of neomycin B and kanamycin A binding Aminoglycosides Modifying Enzymes (AME) and bacterial ribosomal RNA

Interaction of Aminoglycosides with Human Mitochondrial 12S Rrna Carrying the Deafness-Associated Mutation

Studies on the synthesis of neamine-dinucleosides and neamine-PNA conjugates and their interaction with RNA

Modifications of Aminoglycoside Antibiotics Targeting RNA

Modifications Of Aminogocoside Antibiotics Targeting Rna

Convenient synthesis of urea-linked hydroxyl-alkylamine derivatives of aminoglycosides

Regioselective Modification of Amino Groups in Aminoglycosides Based on Cyclic Carbamate Formation

Aminoglycoside Mimetics As Small-Molecule Drugs Targeting RNA

Resolving the intricate binding of neomycin B to multiple binding motifs of a neomycin-sensing riboswitch aptamer by native top-down mass spectrometry and NMR spectroscopy

Two-dimensional combinatorial screening of a bacterial rRNA A-site-like motif library: defining privileged asymmetric internal loops that bind aminoglycosides

Design, Synthesis, and Bioassay of 2 '-Modified Kanamycin A